77 related articles for article (PubMed ID: 23891184)
1. Psammaplysin F: a unique inhibitor of bacterial chromosomal partitioning.
Ramsey DM; Amirul Islam M; Turnbull L; Davis RA; Whitchurch CB; McAlpine SR
Bioorg Med Chem Lett; 2013 Sep; 23(17):4862-6. PubMed ID: 23891184
[TBL] [Abstract][Full Text] [Related]
2. Psammaplysin F, a new bromotyrosine derivative from a sponge, Aplysinella sp.
Liu S; Fu X; Schmitz FJ; Kelly-Borges M
J Nat Prod; 1997 Jun; 60(6):614-5. PubMed ID: 9214734
[TBL] [Abstract][Full Text] [Related]
3. Cytotoxic psammaplysin analogues from a Suberea sp. marine sponge and the role of the spirooxepinisoxazoline in their activity.
Lee YJ; Han S; Lee HS; Kang JS; Yun J; Sim CJ; Shin HJ; Lee JS
J Nat Prod; 2013 Sep; 76(9):1731-6. PubMed ID: 23964644
[TBL] [Abstract][Full Text] [Related]
4. Ceratinadins E and F, New Bromotyrosine Alkaloids from an Okinawan Marine Sponge
Kurimoto SI; Ohno T; Hokari R; Ishiyama A; Iwatsuki M; Ōmura S; Kobayashi J; Kubota T
Mar Drugs; 2018 Nov; 16(12):. PubMed ID: 30477099
[TBL] [Abstract][Full Text] [Related]
5. Marine bacteria: potential sources for compounds to overcome antibiotic resistance.
Eom SH; Kim YM; Kim SK
Appl Microbiol Biotechnol; 2013 Jun; 97(11):4763-73. PubMed ID: 23640363
[TBL] [Abstract][Full Text] [Related]
6. Psammaplysin F increases the efficacy of bortezomib and sorafenib through regulation of stress granule formation.
Christen KE; Davis RA; Kennedy D
Int J Biochem Cell Biol; 2019 Jul; 112():24-38. PubMed ID: 31022461
[TBL] [Abstract][Full Text] [Related]
7. Psammaplysin H, a new antimalarial bromotyrosine alkaloid from a marine sponge of the genus Pseudoceratina.
Xu M; Andrews KT; Birrell GW; Tran TL; Camp D; Davis RA; Quinn RJ
Bioorg Med Chem Lett; 2011 Jan; 21(2):846-8. PubMed ID: 21190857
[TBL] [Abstract][Full Text] [Related]
8. Psammaplysin C: a new cytotoxic dibromotyrosine-derived metabolite from the marine sponge Druinella (= Psammaplysilla) purpurea.
Copp BR; Ireland CM; Barrows LR
J Nat Prod; 1992 Jun; 55(6):822-3. PubMed ID: 1522422
[TBL] [Abstract][Full Text] [Related]
9. Vancomycin minimum inhibitory concentrations (MICs) for meticillin-resistant Staphylococcus aureus (MRSA) in Hong Kong.
Ip M; Chau SS; Lui SL; Leung E; Ling T
Int J Antimicrob Agents; 2010 Oct; 36(4):386-7. PubMed ID: 20702065
[No Abstract] [Full Text] [Related]
10. Prevalence of nasal carriage of methicillin-resistant Staphylococcus aureus and its antibiotic susceptibility pattern in healthcare workers at Namazi Hospital, Shiraz, Iran.
Askarian M; Zeinalzadeh A; Japoni A; Alborzi A; Memish ZA
Int J Infect Dis; 2009 Sep; 13(5):e241-7. PubMed ID: 19269873
[TBL] [Abstract][Full Text] [Related]
11. Manuka honey inhibits cell division in methicillin-resistant Staphylococcus aureus.
Jenkins R; Burton N; Cooper R
J Antimicrob Chemother; 2011 Nov; 66(11):2536-42. PubMed ID: 21903658
[TBL] [Abstract][Full Text] [Related]
12. Antimalarial bromotyrosine derivatives from the Australian marine sponge Hyattella sp.
Yang X; Davis RA; Buchanan MS; Duffy S; Avery VM; Camp D; Quinn RJ
J Nat Prod; 2010 May; 73(5):985-7. PubMed ID: 20462236
[TBL] [Abstract][Full Text] [Related]
13. Restoring methicillin-resistant Staphylococcus aureus susceptibility to β-lactam antibiotics.
Tan CM; Therien AG; Lu J; Lee SH; Caron A; Gill CJ; Lebeau-Jacob C; Benton-Perdomo L; Monteiro JM; Pereira PM; Elsen NL; Wu J; Deschamps K; Petcu M; Wong S; Daigneault E; Kramer S; Liang L; Maxwell E; Claveau D; Vaillancourt J; Skorey K; Tam J; Wang H; Meredith TC; Sillaots S; Wang-Jarantow L; Ramtohul Y; Langlois E; Landry F; Reid JC; Parthasarathy G; Sharma S; Baryshnikova A; Lumb KJ; Pinho MG; Soisson SM; Roemer T
Sci Transl Med; 2012 Mar; 4(126):126ra35. PubMed ID: 22440737
[TBL] [Abstract][Full Text] [Related]
14. Isolation and structural elucidation of armeniaspirols A-C: potent antibiotics against gram-positive pathogens.
Dufour C; Wink J; Kurz M; Kogler H; Olivan H; Sablé S; Heyse W; Gerlitz M; Toti L; Nußer A; Rey A; Couturier C; Bauer A; Brönstrup M
Chemistry; 2012 Dec; 18(50):16123-8. PubMed ID: 23143837
[TBL] [Abstract][Full Text] [Related]
15. Isolation and characterization of two novel antibacterial cyclic hexapeptides from Streptomyces alboflavus 313.
Ji Z; Qiao G; Wei S; Fan L; Wu W
Chem Biodivers; 2012 Aug; 9(8):1567-78. PubMed ID: 22899617
[TBL] [Abstract][Full Text] [Related]
16. Anti-methicillin-resistant Staphylococcus aureus (MRSA) activity of MC21-B, an antibacterial compound produced by the marine bacterium Pseudoalteromonas phenolica O-BC30T.
Isnansetyo A; Kamei Y
Int J Antimicrob Agents; 2009 Aug; 34(2):131-5. PubMed ID: 19329285
[TBL] [Abstract][Full Text] [Related]
17. High-throughput identification of antibacterials against methicillin-resistant Staphylococcus aureus (MRSA) and the transglycosylase.
Cheng TJ; Wu YT; Yang ST; Lo KH; Chen SK; Chen YH; Huang WI; Yuan CH; Guo CW; Huang LY; Chen KT; Shih HW; Cheng YS; Cheng WC; Wong CH
Bioorg Med Chem; 2010 Dec; 18(24):8512-29. PubMed ID: 21075637
[TBL] [Abstract][Full Text] [Related]
18. Cytotoxic Psammaplysin Analogues from the Verongid Red Sea Sponge
Shaala LA; Youssef DTA
Biomolecules; 2019 Dec; 9(12):. PubMed ID: 31817954
[TBL] [Abstract][Full Text] [Related]
19. Characterization of methicillin-resistant Staphylococcus aureus displaying increased MICs of ceftaroline.
Mendes RE; Tsakris A; Sader HS; Jones RN; Biek D; McGhee P; Appelbaum PC; Kosowska-Shick K
J Antimicrob Chemother; 2012 Jun; 67(6):1321-4. PubMed ID: 22398650
[TBL] [Abstract][Full Text] [Related]
20. New drugs for methicillin-resistant Staphylococcus aureus: an update.
Kumar K; Chopra S
J Antimicrob Chemother; 2013 Jul; 68(7):1465-70. PubMed ID: 23429643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
